Triphenylphosphine → HCID 86640600、化合物
反応式
[CH2:1]([N:3]([CH2:26][CH3:27])[C:4]1[CH:9]=[C:8]([C:10]2[O:14][N:13]=[C:12]([C:15]3[CH:20]=[C:19]([CH3:21])[C:18]([OH:22])=[C:17]([CH2:23][CH3:24])[CH:16]=3)[N:11]=2)[CH:7]=[C:6]([CH3:25])[N:5]=1)[CH3:2].C1C=CC(P(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1.[CH2:47]1[O:49][C@@H:48]1[CH2:50]O.CCOC(/N=N/C(OCC)=O)=O>C1COCC1>[CH2:26]([N:3]([CH2:1][CH3:2])[C:4]1[CH:9]=[C:8]([C:10]2[O:14][N:13]=[C:12]([C:15]3[CH:20]=[C:19]([CH3:21])[C:18]([O:22][CH2:50][C@@H:48]4[CH2:47][O:49]4)=[C:17]([CH2:23][CH3:24])[CH:16]=3)[N:11]=2)[CH:7]=[C:6]([CH3:25])[N:5]=1)[CH3:27]参加物
6
実験手順
To a solution of 4-[5-(2-diethylamino-6-methyl-pyridin-4-yl)-[1,2,4]oxadiazol-3-yl]-2-ethyl-6-methyl-phenol (110 mg, 0.30 mmol) in THF (9 mL), PPh3 (150 mg, 0.57 mmol) and (R)-glycidol (42 mg, 0.57 mmol) are added. The mixture is cooled to 0° C. before DEAD (248 mg, 0.57 mmol) is added. The mixture stirred for 1 h and is warmed to rt. The solvent is evaporated and the crude product is purified by CC on silica gel eluting with heptane:EA 7:3 to give diethyl-{4-[3-((S)-3-ethyl-5-methyl-4-oxiranylmethoxy-phenyl)-[1,2,4]oxadiazol-5-yl]-6-methyl-pyridin-2-yl}-amine (119 mg) as a yellow oil; LC-MS: tR=0.95 min; [M+1]+=423.21.
後処理
- additionis added
- customThe solvent is evaporated
- customthe crude product is purified by CC on silica gel eluting with heptane:EA 7:3
出典と根拠
- ORDレコード
- ord-69892942e7574e0da8a314d22dff35fc
- 出典データセット
- uspto-grants-2013_11
- 特許番号
- US08592460B2
反応ノート
読み込み中…